{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:26:31Z","timestamp":1774877191094,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.coi.2012.08.013","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T00:36:09Z","timestamp":1347669369000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Creating genetic resistance to HIV"],"prefix":"10.1016","volume":"24","author":[{"given":"John C","family":"Burnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Zaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2012.08.013_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2011.12.015","article-title":"Hematopoietic-stem-cell-based gene therapy for HIV disease","volume":"10","author":"Kiem","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2012.08.013_bib0010","first-page":"607","article-title":"Towards an HIV cure: a global scientific strategy","volume":"2","author":"Deeks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2012.08.013_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"Buzon","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","article-title":"Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy","volume":"24","author":"Yukl","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.coi.2012.08.013_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/335395a0","article-title":"Gene therapy. Intracellular immunization","volume":"335","author":"Baltimore","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.coi.2012.08.013_bib0035","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1093\/hmg\/ddr160","article-title":"Ex vivo gene therapy for HIV-1 treatment","volume":"20","author":"Scherer","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2012.08.013_bib0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/mt.2010.269","article-title":"Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells","volume":"19","author":"Kambal","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1089\/hum.2010.050","article-title":"Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter","volume":"21","author":"Kamata","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtbi.2005.05.005","article-title":"Impact of gene-modified T cells on HIV infection dynamics","volume":"238","author":"von Laer","year":"2006","journal-title":"J. Theor Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1742-4690-7-83","article-title":"In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy","volume":"7","author":"Applegate","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.coi.2012.08.013_bib0060","doi-asserted-by":"crossref","first-page":"e12357","DOI":"10.1371\/journal.pone.0012357","article-title":"Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection","volume":"5","author":"Kimpel","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2012.08.013_bib0065","doi-asserted-by":"crossref","first-page":"e1000883","DOI":"10.1371\/journal.pcbi.1000883","article-title":"Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles","volume":"6","author":"Aviran","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0070_1","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2012.08.013_bib0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0b013e328340fe28","article-title":"Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2","volume":"25","author":"Hutter","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.coi.2012.08.013_bib0085","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1172\/JCI40767","article-title":"Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates","volume":"120","author":"Beard","year":"2010","journal-title":"J. Clin Invest"},{"key":"10.1016\/j.coi.2012.08.013_bib0090","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coi.2012.08.013_bib0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coi.2012.08.013_bib0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"Holt","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coi.2012.08.013_bib0105_1","doi-asserted-by":"crossref","first-page":"e1002020","DOI":"10.1371\/journal.ppat.1002020","article-title":"Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases","volume":"7","author":"Wilen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2012.08.013_bib0110_1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/mt.2011.310","article-title":"Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment","volume":"20","author":"Yuan","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0115","doi-asserted-by":"crossref","first-page":"e16825","DOI":"10.1371\/journal.pone.0016825","article-title":"Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI","volume":"6","author":"Aubert","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2012.08.013_bib0120","doi-asserted-by":"crossref","first-page":"e31576","DOI":"10.1371\/journal.pone.0031576","article-title":"Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase","volume":"7","author":"Mariyanna","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2012.08.013_bib0125","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1141453","article-title":"HIV-1 proviral DNA excision using an evolved recombinase","volume":"316","author":"Sarkar","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.coi.2012.08.013_bib0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JVI.78.2.568-575.2004","article-title":"Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides","volume":"78","author":"Egelhofer","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0135","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mt.sj.6300124","article-title":"Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus","volume":"15","author":"van Lunzen","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0140","doi-asserted-by":"crossref","first-page":"e7693","DOI":"10.1371\/journal.pone.0007693","article-title":"Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection","volume":"4","author":"Trobridge","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2012.08.013_bib0145_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/mt.2011.30","article-title":"Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection","volume":"19","author":"Egerer","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0150","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.00666-08","article-title":"Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46","volume":"83","author":"Hermann","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2008.10.007","article-title":"Knockdown screens to knockout HIV-1","volume":"135","author":"Goff","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.coi.2012.08.013_bib0160_1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/mt.2012.6","article-title":"Lens epithelium-derived growth factor\/p75 qualifies as a target for HIV gene therapy in the NSG mouse model","volume":"20","author":"Vets","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0165","doi-asserted-by":"crossref","first-page":"a006940","DOI":"10.1101\/cshperspect.a006940","article-title":"HIV restriction factors and mechanisms of evasion","volume":"2","author":"Malim","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0170","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1128\/JVI.01925-10","article-title":"N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-4690-5-72","article-title":"APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication","volume":"5","author":"Li","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.coi.2012.08.013_bib0180_1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/hum.2010.012","article-title":"Characterization of anti-HIV activity mediated by R88-APOBEC3G mutant fusion proteins in CD4+ T cells, peripheral blood mononuclear cells, and macrophages","volume":"22","author":"Ao","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/hum.2007.108","volume":"19","author":"Anderson","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0190","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI39354","article-title":"Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components","volume":"119","author":"Neagu","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2012.08.013_bib0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0200","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/hum.1998.9.16-2407","article-title":"A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA","volume":"9","author":"Wong-Staal","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0205","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/10430349950018067","article-title":"A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins","volume":"10","author":"Cooper","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/viro.2000.0536","article-title":"Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5","volume":"276","author":"Feng","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.coi.2012.08.013_bib0215","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jgm.705","article-title":"Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients","volume":"7","author":"Macpherson","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/104303404322886101","article-title":"Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients","volume":"15","author":"Amado","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrm2738","article-title":"Regulatory roles of natural antisense transcripts","volume":"10","author":"Faghihi","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0235","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2012.08.013_bib0240_1","doi-asserted-by":"crossref","first-page":"e1002015","DOI":"10.1371\/journal.pcbi.1002015","article-title":"Autonomous targeting of infectious superspreaders using engineered transmissible therapies","volume":"7","author":"Metzger","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0245","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1128\/JVI.77.18.10028-10036.2003","article-title":"Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection","volume":"77","author":"Weinberger","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V94.1.368.413a47_368_371","article-title":"A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children","volume":"94","author":"Kohn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.coi.2012.08.013_bib0255_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2012.08.013_bib0260","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","article-title":"Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition","volume":"78","author":"Das","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/JVI.80.2.571-577.2006","article-title":"Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs","volume":"80","author":"Sabariegos","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0270_1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/mt.2012.3","article-title":"HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites","volume":"20","author":"Shah","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2008.09.008","article-title":"HIV evades RNA interference directed at TAR by an indirect compensatory mechanism","volume":"4","author":"Leonard","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2012.08.013_bib0280","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1093\/nar\/gkq460","article-title":"Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors","volume":"38","author":"Saayman","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2012.08.013_bib0285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mt.6300382","article-title":"Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition","volume":"16","author":"ter Brake","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-60761-588-0_8","article-title":"Strategies in designing multigene expression units to downregulate HIV-1","volume":"623","author":"Zhang","year":"2010","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.coi.2012.08.013_bib0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-7-52","article-title":"Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs","volume":"7","author":"Schopman","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.coi.2012.08.013_bib0300","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2012.011","article-title":"Endogenous MCM7 miRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy","author":"Chung","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0305","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/mt.2009.187","article-title":"Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy","volume":"17","author":"Anderson","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0310_1","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1128\/JVI.06300-11","article-title":"Generation of an HIV-1-resistant immune system with CD34+ hematopoietic stem cells transduced with a triple-combination Anti-HIV lentiviral vector","volume":"86","author":"Walker","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2012.08.013_bib0315_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/gt.2009.118","article-title":"Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo","volume":"17","author":"Kiem","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0320","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"Burnett","year":"2011","journal-title":"Biotechnol J"},{"key":"10.1016\/j.coi.2012.08.013_bib0325","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2007-08-107466","article-title":"Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl","volume":"111","author":"Abdel-Azim","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2012.08.013_bib0330","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mt.2011.8","article-title":"Long-term regulation of genetically modified primary hematopoietic cells in dogs","volume":"19","author":"Okazuka","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2012.08.013_bib0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(00)00085-5","article-title":"Ribozyme therapy for HIV infection","volume":"44","author":"Rossi","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.coi.2012.08.013_bib0340","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/jvi.71.5.4079-4085.1997","article-title":"Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA","volume":"71","author":"Liu","year":"1997","journal-title":"J Virol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791512001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791512001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:26:52Z","timestamp":1760603212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791512001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0952791512001367"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2012.08.013","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creating genetic resistance to HIV","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2012.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}